Report Detail
Global (United States, European Union and China) Ziprasidone Market Research Report 2019-2025
- RnM3689637 |
- 22 August, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Chemical & Material
Ziprasidone, sold under the brand name Geodon among others, is an atypical antipsychotic that is used for the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder. Its immediate release intramuscular injection form is approved for acute agitation in people with schizophrenia.
In 2019, the market size of Ziprasidone is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Ziprasidone.
This report studies the global market size of Ziprasidone, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Ziprasidone production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Pfizer
Sandoz
Lupin Pharmaceuticals
Mylan Pharmaceuticals
Apotex
Dr. Reddy's Laboratories
Wockhardt
Aurobindo
Macleods Pharmaceuticals
Zydus Pharmaceuticals
Market Segment by Product Type
Oral capsule
Injection
Market Segment by Application
Hospital
Drug store
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Ziprasidone status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Ziprasidone manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Ziprasidone are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Ziprasidone Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Oral capsule
- 1.3.3 Injection
- 1.4 Market Segment by Application
- 1.4.1 Global Ziprasidone Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Drug store
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Ziprasidone Production Value 2014-2025
- 2.1.2 Global Ziprasidone Production 2014-2025
- 2.1.3 Global Ziprasidone Capacity 2014-2025
- 2.1.4 Global Ziprasidone Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Ziprasidone Market Size CAGR of Key Regions
- 2.2.2 Global Ziprasidone Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Ziprasidone Capacity by Manufacturers
- 3.1.2 Global Ziprasidone Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Ziprasidone Revenue by Manufacturers (2014-2019)
- 3.2.2 Ziprasidone Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Ziprasidone Market Concentration Ratio (CR5 and HHI)
- 3.3 Ziprasidone Price by Manufacturers
- 3.4 Key Manufacturers Ziprasidone Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Ziprasidone Market
- 3.6 Key Manufacturers Ziprasidone Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Oral capsule Production and Production Value (2014-2019)
- 4.1.2 Injection Production and Production Value (2014-2019)
- 4.2 Global Ziprasidone Production Market Share by Type
- 4.3 Global Ziprasidone Production Value Market Share by Type
- 4.4 Ziprasidone Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Ziprasidone Consumption by Application
6 Production by Regions
- 6.1 Global Ziprasidone Production (History Data) by Regions 2014-2019
- 6.2 Global Ziprasidone Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Ziprasidone Production Growth Rate 2014-2019
- 6.3.2 United States Ziprasidone Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Ziprasidone Import & Export
- 6.4 European Union
- 6.4.1 European Union Ziprasidone Production Growth Rate 2014-2019
- 6.4.2 European Union Ziprasidone Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Ziprasidone Import & Export
- 6.5 China
- 6.5.1 China Ziprasidone Production Growth Rate 2014-2019
- 6.5.2 China Ziprasidone Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Ziprasidone Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Ziprasidone Consumption by Regions
- 7.1 Global Ziprasidone Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Ziprasidone Consumption by Type
- 7.2.2 United States Ziprasidone Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Ziprasidone Consumption by Type
- 7.3.2 European Union Ziprasidone Consumption by Application
- 7.4 China
- 7.4.1 China Ziprasidone Consumption by Type
- 7.4.2 China Ziprasidone Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Ziprasidone Consumption by Type
- 7.5.2 Rest of World Ziprasidone Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Pfizer
- 8.1.1 Pfizer Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Ziprasidone
- 8.1.4 Ziprasidone Product Introduction
- 8.1.5 Pfizer Recent Development
- 8.2 Sandoz
- 8.2.1 Sandoz Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Ziprasidone
- 8.2.4 Ziprasidone Product Introduction
- 8.2.5 Sandoz Recent Development
- 8.3 Lupin Pharmaceuticals
- 8.3.1 Lupin Pharmaceuticals Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Ziprasidone
- 8.3.4 Ziprasidone Product Introduction
- 8.3.5 Lupin Pharmaceuticals Recent Development
- 8.4 Mylan Pharmaceuticals
- 8.4.1 Mylan Pharmaceuticals Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Ziprasidone
- 8.4.4 Ziprasidone Product Introduction
- 8.4.5 Mylan Pharmaceuticals Recent Development
- 8.5 Apotex
- 8.5.1 Apotex Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Ziprasidone
- 8.5.4 Ziprasidone Product Introduction
- 8.5.5 Apotex Recent Development
- 8.6 Dr. Reddy's Laboratories
- 8.6.1 Dr. Reddy's Laboratories Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Ziprasidone
- 8.6.4 Ziprasidone Product Introduction
- 8.6.5 Dr. Reddy's Laboratories Recent Development
- 8.7 Wockhardt
- 8.7.1 Wockhardt Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Ziprasidone
- 8.7.4 Ziprasidone Product Introduction
- 8.7.5 Wockhardt Recent Development
- 8.8 Aurobindo
- 8.8.1 Aurobindo Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Ziprasidone
- 8.8.4 Ziprasidone Product Introduction
- 8.8.5 Aurobindo Recent Development
- 8.9 Macleods Pharmaceuticals
- 8.9.1 Macleods Pharmaceuticals Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Ziprasidone
- 8.9.4 Ziprasidone Product Introduction
- 8.9.5 Macleods Pharmaceuticals Recent Development
- 8.10 Zydus Pharmaceuticals
- 8.10.1 Zydus Pharmaceuticals Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Ziprasidone
- 8.10.4 Ziprasidone Product Introduction
- 8.10.5 Zydus Pharmaceuticals Recent Development
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Ziprasidone Capacity, Production Forecast 2019-2025
- 9.1.2 Global Ziprasidone Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Ziprasidone Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Ziprasidone Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Ziprasidone Production Forecast by Type
- 9.7.2 Global Ziprasidone Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Ziprasidone Sales Channels
- 10.2.2 Ziprasidone Distributors
- 10.3 Ziprasidone Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Ziprasidone. Industry analysis & Market Report on Ziprasidone is a syndicated market report, published as Global (United States, European Union and China) Ziprasidone Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Ziprasidone market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
